Accutane Trial Results in $18M Award for Two Lawsuits

A trial in New Jersey state court has resulted in a verdict of $18 million, including $9 million each awarded to two plaintiffs who filed a lawsuit over bowel problems from Accutane, an acne medication developed by Roche, which is the subject thousands of other similar claims brought by individuals throughout the United States.

The jury found that Roche failed to adequately warn about the risk of inflammatory bowel disease from Accutane, awarding Kathleen Rossitto and Riley Wilkinson $9 million in compensatory damages apiece. However, the same jury returned defense verdicts in lawsuits brought by Rebecca Reynolds and Jason Young, finding that any failure to warn was not the cause of injuries suffered by those plaintiffs.

Accutane, known generically as isotretinoin, has been used by more than 16 million people worldwide since it was first introduced in the early 1980s as a treatment for severe acne.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

Roche and manufacturers of generic versions of the drug, currently face nearly 8,000 Accutane lawsuits in New Jersey state court, where the litigation is centralized as part of a mass tort before Judge Carl E. Higbee in Atlantic County.

All of the lawsuits involve similar claims that former users of the acne medication developed severe and debilitaitng bowel problems as a result of Accutane, including inflammatory bowel disease (IBD), ulcerative colitis and Crohn’s disease. Complaints allege that the injuries could have been provided if the manufacturers had provided adequate warnings with Accutane.

Roche stopped selling Accutane in June 2009, citing the increasing costs associated with the lawsuits over Accutane and falling sales. However, the medication remains available from a number of different generic drug makers, sold under names like Claravis, Sotret, Amnesteem and generic isotretinoin.

The first Accutane trial was presented to a jury in April 2007, and about a dozen cases have made it to trial since that time, resulting in several multi-million dollar jury awards for damages caused by Accutane.


"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Onewheel "Nosedive" Lawsuit Filed Days Before Manufacturer Recalled Electric Skateboards (Posted today)

A OneWheel nosedive lawsuit claims the battery-operated scooter is defectively designed, causing riders to suffer serious injuries when the device suddenly stops and pitches forward.

Problems with Philips CPAP Machines Reported 11 Years Before Recall Issued By Manufacturer
Problems with Philips CPAP Machines Reported 11 Years Before Recall Issued By Manufacturer (Posted 4 days ago)

A ProPublica report reveals that Philips officials hid thousands of reports of problems with sound abatement foam used in millions of CPAP machines, failing to recall the devices for more than a decade after receiving the first complaints.